September 30, 2016 3:01 PM ET


Company Overview of Prognomix, Inc.

Key Executives for Prognomix, Inc.

NameBoard RelationshipsTitleAge
Normand Balthazard No RelationshipsChief Executive Officer--
Pavel Hamet OQ, FRCP(C), FRSM, FAHA, FCAS45 RelationshipsFounder, President, Director and Member of The Scientific Advisory Board--
Johanne Tremblay CSO8 RelationshipsCo-Founder, President of the Scientific Advisory Board, CSO, Vice-President and Director--
Marc-André Blais No RelationshipsSecretary of the Board--
John Chalmers 8 RelationshipsSenior Director, Director and Member of the Scientific Advisory Board--

Prognomix, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Francesco Bellini OC, GU, Ph.D. 35 RelationshipsKlox Technologies Inc.68
Pavel Hamet OQ, FRCP(C), FRSM, FAHA, FCAS 45 RelationshipsPrognomix, Inc.--
Johanne Tremblay CSO 8 RelationshipsPrognomix, Inc.--
John Chalmers 8 RelationshipsPrognomix, Inc.--
Michel Marre 8 RelationshipsPrognomix, Inc.--
View All Board Members

Prognomix, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board CSOJohanne Tremblay8 Relationships7 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Prognomix, Inc. CEO Compensation
Industry Average


Medibio Limited Announces Resignation of James Campbell as Non-Executive Director
September 30, 2016 3:22 AM ET
Threshold Pharmaceuticals Inc. to Implement Workforce Reduction; Announces Resignation of Stewart Kroll as Chief Operating Officer
September 29, 2016 9:20 PM ET
Kite Pharma, Inc. Appoints Christine Cassiano as Senior Vice President of Corporate Communications and Investor Relations
September 29, 2016 8:05 PM ET
Diffusion Pharmaceuticals Inc. Announces Establishment of New Scientific Advisory Board
September 29, 2016 2:05 PM ET
Flexion Therapeutics, Inc. Announces Appointment of John Magee as Vice President of Sales
September 29, 2016 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Prognomix, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at